United Arab Emirates · Delayed Price · Currency is AED Fertiglobe Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw revenue and EBITDA rise over 30% year-over-year, driven by high urea prices and resilient operations despite Middle East disruptions. U.A.E. tax cuts and early cost optimization boosted EPS, while market conditions remain tight and CapEx guidance is unchanged.
Fiscal Year 2025
-
Q4 and full-year 2025 saw robust revenue and profit growth, driven by higher urea and ammonia prices, increased volumes, and strategic initiatives. Strong free cash flow enabled a higher dividend and share buybacks, while market fundamentals remain favorable for 2026.
-
Q3 2025 saw revenues up 53% year-over-year and adjusted EBITDA up 69%, driven by higher urea prices, operational improvements, and strategic initiatives. A one-off $720 million goodwill tax settlement in Egypt boosted reported profit, while strong market conditions and progress on growth targets support a positive outlook.
-
Q2 2025 saw strong year-over-year growth in revenue and EBITDA, despite gas disruptions in Egypt impacting volumes. Tight global nitrogen markets and robust demand are driving higher prices, supporting a positive outlook and potential upside for dividends.
-
GROW 2030 strategy targets $1B+ EBITDA by 2030, leveraging ADNOC support, operational excellence, and downstream expansion. Q1 2025 saw revenue up 26% and EBITDA up 45% year-on-year, with strong cash conversion and resilience measures in place.
Fiscal Year 2024
-
Q4 and full-year 2024 saw lower revenues and profits due to market and operational challenges, but strategic shipment deferrals and cost initiatives position the company for a stronger 2025. Tight fertilizer markets, high gas prices, and new low-carbon projects support a positive outlook.
-
Q3 2024 saw revenues of $496M, down 6% year-over-year, with adjusted EBITDA at $176M and net profit impacted by provisions for Algerian gas pricing. ADNOC's transfer of low-carbon ammonia projects will more than double capacity by 2029, supporting a positive long-term outlook.
-
Q2 and H1 2024 saw lower revenues and EBITDA due to market volatility and gas disruptions, but production efficiency improved and strategic projects advanced. The company remains on track for cost and EBITDA targets, with a strong balance sheet and positive credit outlook.